Sterling Analytical provides supplement and nutritional heavy metals testing in accordance with USP General Chapter <2232> (Elemental Contaminants in Dietary Supplements), quantifying arsenic, cadmium, lead, and mercury — the four elements this chapter specifically focuses on — by ICP-OES and ICP-MS. Our testing supports dietary supplement manufacturers, ingredient suppliers, and contract manufacturers who need defensible compliance data across raw materials, finished products, or both.
USP <2232> is built on the same Permitted Daily Exposure (PDE) logic that underlies ICH Q3D for pharmaceutical drug products — covered in more detail on our Pharmaceutical Heavy Metals Testing page — but it’s a genuinely distinct regulatory chapter with its own specific limits, compliance options, and derivation logic, tailored to how dietary supplements are actually consumed and regulated differently from prescription drug products. Understanding that distinction matters, because applying drug-product elemental impurity logic directly to a supplement (or vice versa) can lead to testing against the wrong specification entirely.
This is worth explaining clearly, because dietary supplements occupy a distinct regulatory category from pharmaceutical drugs, and the elemental contaminant framework reflects that.
USP <2232> focuses specifically on four elements of toxicological concern: arsenic, cadmium, lead, and mercury — a narrower scope than ICH Q3D’s full 24-element, four-class system, reflecting the chapter’s specific focus on contaminants most likely to be present in dietary ingredients (commonly plant materials, minerals, and other naturally sourced inputs) rather than the full range of process-related and catalyst-derived impurities relevant to synthetic drug substances. The Permitted Daily Exposure values in <2232> are also derived differently than ICH Q3D’s drug-product PDEs: they’re based on the Provisional Tolerable Weekly Intake (PTWI) figures published by the Food and Agriculture Organization and World Health Organization, specifically adjusted to subtract expected background daily exposure to each element from food, air, and drinking water that essentially everyone is already exposed to regardless of supplement use.
This background-exposure adjustment is a genuinely important conceptual difference from drug-product PDEs: a dietary supplement PDE isn’t asking “what level is safe in isolation,” it’s asking “what additional level is safe on top of what people are already getting from their normal diet and environment” — a more holistic framing appropriate to a product category that, unlike most drugs, people may consume daily over very long periods alongside a varied diet that already contains some baseline level of these same elements.
For a dietary supplement with a maximum daily intake of 10 grams or less, USP <2232> establishes individual component limits as follows:
These figures apply specifically under the Individual Component Option (discussed below) for products at or below the 10 gram per day intake threshold; products consumed in larger daily quantities, or specific dietary ingredient monographs with their own stated limits, may have different applicable figures.
This is a genuinely important technical nuance built into USP <2232>, and it directly affects testing strategy and cost, so it’s worth understanding rather than testing for full speciation by default on every sample.
Arsenic in dietary ingredients can occur in both inorganic and organic forms, and inorganic arsenic is considered substantially more toxicologically significant than most organic arsenic species. USP <2232> allows total arsenic to be measured first under the assumption that all of it is inorganic — a conservative, simpler screening approach. Only if total arsenic exceeds the inorganic arsenic limit does the chapter require a dedicated speciation procedure to determine how much of that total is actually the more concerning inorganic form. This means a sample can fail an initial total-arsenic screen but still ultimately pass once speciation confirms the inorganic fraction is within limits — a meaningful distinction for ingredients like certain seaweed-derived materials, which can be naturally high in total arsenic but predominantly in less concerning organic forms.
Mercury works similarly in reverse logic: methylmercury (the more toxicologically significant organic form) determination is specifically not required if total mercury already falls below the methylmercury limit itself, since if total mercury is already below the stricter methylmercury threshold, the methylmercury fraction necessarily is too.
Both of these speciation rules exist to avoid unnecessary analytical burden — there’s no need to run an expensive, more complex speciation procedure if the simpler total-element screen already demonstrates compliance, but speciation becomes essential precisely when the simpler screen doesn’t clear the bar on its own.
Dietary supplements span an unusually broad range of matrices — botanical extracts, mineral-based ingredients, protein powders, gummies, capsules, and finished multi-ingredient formulations — each requiring digestion conditions suited to its specific composition.
Our approach:
USP <2232> offers three distinct paths to demonstrating compliance, and choosing the right one for your situation affects both testing cost and where in your supply chain testing makes the most sense.
Finished Product Analysis involves testing a representative serving of the finished dietary supplement directly against the PDE limits — generally applicable and often the most straightforward conceptually, though it means testing has to happen on the final formulated product rather than earlier in the supply chain.
Individual Component Option applies to finished products with a maximum daily intake of 10 grams or less, allowing each individual ingredient to be tested separately against the component limits shown above, with the product considered compliant if every individual component meets its limit. This is the option that lets ingredient suppliers test and certify components independently, before they’re combined into a multi-ingredient finished product.
Summation Option is used for products consumed in quantities greater than 10 grams per day, or where an individual component’s contaminant level exceeds the standard individual component limit — in this case, contaminant levels across all components are summed and compared against the total PDE, accounting for the actual proportional contribution of each ingredient to the overall daily dose.
Choosing between these options often comes down to where in your supply chain testing makes the most practical sense: an ingredient supplier providing raw materials to multiple finished-product manufacturers often benefits from individual component testing and certification, while a finished-product manufacturer combining several ingredients into a single formulation may find finished product analysis simpler, particularly once a formulation is locked and stable.
Understanding how these calculations actually work in practice helps demonstrate why generic “heavy metals testing” without product-specific context can miss the mark.
Consider a dietary supplement sold as capsules: serving size of two capsules, each capsule weighing 2.5 grams, with a label directing up to three servings per day. The total daily intake works out to 2.5 grams × 2 capsules × 3 servings = 15 grams per day — which, notably, exceeds the 10 gram per day threshold for the simpler Individual Component Option, meaning this particular product would need to use the Summation Option instead, with contaminant levels calculated proportionally against the actual 15 gram daily intake rather than the standard 10 gram reference figure.
This kind of calculation — converting label-stated serving size and maximum daily servings into an actual gram-per-day intake figure, then determining which compliance option and which specific limits apply — is a necessary step before testing results can even be properly interpreted against a compliance threshold, and it’s part of the conversation we have with clients scoping a testing program rather than just running a generic panel and reporting raw concentrations.
Required sample size: 1–5 grams for solid materials (capsules, powders, gummies), or appropriate quantity for liquid formulations depending on required sensitivity.
Packaging guidelines:
Standard turnaround: 3–5 business days Rush service: 24–48 hours available
Pricing starts from $150 per sample for the standard four-element panel (As, Cd, Pb, Hg), with arsenic or mercury speciation priced separately when required.
Clients receive a Certificate of Analysis suitable for regulatory documentation and quality assurance.
Your COA includes:
All results are supported by CRM-traceable calibration, with duplicates and matrix spikes performed on each analytical batch.
Sterling Analytical applies methods aligned with USP <2232>:
Explore related services:
Submit your product details, including serving size and maximum daily servings, to receive a tailored quote and recommended testing approach.
